Effient Labeling Could Give Edge Against Plavix Through Pharmacogenetics
This article was originally published in The Pink Sheet Daily
Executive Summary
Lilly/Daiichi Sankyo's prasugrel has carefully constructed label to control risk of bleeding - but it also includes a pharmacogenetic argument that Effient works in clopidogrel non-responders.